The incurable wound revisited: progress in human rabies prevention?

[1]  C. Rupprecht,et al.  The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure. , 2000, Journal of immunological methods.

[2]  J. Childs,et al.  Recommendations of a National Working Group on Prevention and Control of Rabies in the United States. Article III: Rabies in wildlife. National Working Group on Rabies Prevention and Control. , 1999, Journal of the American Veterinary Medical Association.

[3]  C. Hanlon,et al.  Recommendations of a national working group on prevention and control of rabies in the United States. Article II: Laboratory diagnosis of rabies. The National Working Group on Rabies Prevention and Control. , 1999, Journal of the American Veterinary Medical Association.

[4]  J. Lang,et al.  Perspectives Perspectives Perspectives Perspectives Perspectives Disincentives for Orphan Vaccine Development Development of Orphan Vaccines: an Industry Perspective , 2022 .

[5]  C. Hanlon,et al.  Article I: Prevention and education regarding rabies in human beings. National Working Group on Rabies Prevention and Control. , 1999, Journal of the American Veterinary Medical Association.

[6]  J. Lang,et al.  Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, Vero-cell rabies vaccine. , 1998, Acta tropica.

[7]  L. Rotz,et al.  Large-scale human exposures to rabid or presumed rabid animals in the United States: 22 cases (1990-1996). , 1998, Journal of the American Veterinary Medical Association.

[8]  T. Hulland.  A Biographical History of Veterinary Pathology , 1997 .

[9]  M. G. Smith,et al.  Mass human exposure to rabies in New Hampshire: exposures, treatment, and cost. , 1996, American journal of public health.

[10]  V. Sitprija,et al.  Heterologous Antisera and Antivenins Are Essential Biologicals: Perspectives on a Worldwide Crisis , 1996, Annals of Internal Medicine.

[11]  V. Sitprija,et al.  Failure of postexposure treatment of rabies in children. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  C. Rupprecht,et al.  Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Köhler,et al.  A rabies-specific human monoclonal antibody that protects mice against lethal rabies. , 1991, Hybridoma.

[14]  J. Bouvet,et al.  Human monoclonal antibodies specific for the rabies virus glycoprotein and N protein. , 1990, The Journal of general virology.

[15]  P. Casali,et al.  Biological characterization of human monoclonal antibodies to rabies virus , 1990, Journal of virology.

[16]  S. Chutivongse,et al.  Equine rabies immune globulin: a product with an undeserved poor reputation. , 1990, The American journal of tropical medicine and hygiene.

[17]  N. Harindranath,et al.  Clonal analysis of a human antibody response. Quantitation of precursors of antibody-producing cells and generation and characterization of monoclonal IgM, IgG, and IgA to rabies virus , 1990, The Journal of experimental medicine.

[18]  C. Rupprecht,et al.  Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies. , 1989, The Journal of clinical investigation.

[19]  S. Chutivongse,et al.  Failure of rabies postexposure treatment in Thailand. , 1989, Vaccine.

[20]  G. Baer.  Animal models in the pathogenesis and treatment of rabies. , 1988, Reviews of infectious diseases.

[21]  Lin Fang-Tao,et al.  Use of Serum and Vaccine in Combination for Prophylaxis Following Exposure to Rabies , 1988 .

[22]  H. Koprowski,et al.  Mechanisms of rabies virus neutralization by glycoprotein-specific monoclonal antibodies. , 1987, Virology.

[23]  P. Thongcharoen,et al.  Human rabies after late administration of purified chicken embryo cell (PCEC) vaccine without hyperimmune serum. , 1986, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[24]  D. Collins.  Successful protection of humans exposed to rabies infection , 1977 .

[25]  H. Koprowski,et al.  Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum. , 1976, JAMA.

[26]  Ellen Jo Baron,et al.  Manual of clinical microbiology , 1975 .

[27]  T. S. Hosty,et al.  Incidence of reactions to antirabies horse serum. , 1953, Public health reports.

[28]  H. Koprowski,et al.  Use of hyperimmune anti-rabies serum concentrates in experimental rabies. , 1950, The American journal of medicine.

[29]  H. Wilde,et al.  Additional reports of failure to respond to treatment after rabies exposure in Thailand. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  W. Haupt.  Rabies--risk of exposure and current trends in prevention of human cases. , 1999, Vaccine.

[31]  C. Hanlon,et al.  Recommendations of a national working group on prevention and control of rabies in the United States Article I: Prevention and education regarding rabies in human beings , 1999 .

[32]  Mass treatment of humans who drank unpasteurized milk from rabid cows--Massachusetts, 1996-1998. , 1999, MMWR. Morbidity and mortality weekly report.

[33]  H. M.P.,et al.  Human rabies prevention--United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP). , 1999, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[34]  K Fukaya,et al.  [Rabies virus]. , 1997, Nihon rinsho. Japanese journal of clinical medicine.

[35]  M. Pagano,et al.  Survival analysis. , 1996, Nutrition.

[36]  E. Kreuzfelder,et al.  Current and future immunoprophylaxis against human rabies: reduction of treatment failures and errors. , 1994, Current topics in microbiology and immunology.

[37]  A. Notkins,et al.  Production of human monoclonal antibodies against rabies virus. , 1994, Current topics in microbiology and immunology.

[38]  W. Kajiyama,et al.  Development of human monoclonal antibodies to rabies. , 1994, Hybridoma.

[39]  F. Meslin,et al.  Rationale and prospects for rabies elimination in developing countries. , 1994, Current topics in microbiology and immunology.

[40]  Fishbein Db,et al.  Rationale and prospects for rabies elimination in developing countries , 1994 .

[41]  Notkins Al,et al.  Production of human monoclonal antibodies against rabies virus. , 1994 .

[42]  S. Chutivongse,et al.  Purified equine rabies immune globulin: a safe and affordable alternative to human rabies immune globulin. , 1989, Bulletin of the World Health Organization.

[43]  Y. Wang,et al.  Use of serum and vaccine in combination for prophylaxis following exposure to rabies. , 1988, Reviews of infectious diseases.

[44]  M. Baltazard,et al.  [Prevention of human rabies; treatment of the persons bitten by rabid wolves in Iran]. , 1953, Revue d'immunologie et de therapie antimicrobienne.